ProShares Ultra Nasdaq Biotechnology (BIB) Dividend Yield, History & Forecast

ProShares Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund (ETF) listed on the NASDAQ. It pays a current dividend yield of 0.20% ($0.22 per share annually (TTM)). The most recent ex-dividend date was September 23, 2026, with payment scheduled for September 29, 2026. market capitalization is approximately $88M. Review BIB dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

BIB fund composition

BIB holds 274 positions. It charges an expense ratio of 1.17%, and manages $94.8M.

Sector allocation

Healthcare62.9%Financial Services18.9%Cash & Others18.2%

Frequently Asked Questions about ProShares Ultra Nasdaq Biotechnology (BIB)

What is ProShares Ultra Nasdaq Biotechnology's dividend yield?
ProShares Ultra Nasdaq Biotechnology (BIB) pays a current trailing twelve-month dividend yield of 0.20%, which works out to $0.22 per share annually based on the most recent payout schedule.
When does ProShares Ultra Nasdaq Biotechnology pay distributions?
The most recent ex-dividend date was September 23, 2026. The next scheduled dividend payment date is September 29, 2026.
How many years has ProShares Ultra Nasdaq Biotechnology increased its dividend?
ProShares Ultra Nasdaq Biotechnology (BIB) has increased its dividend for 3 consecutive years.
What does ProShares Ultra Nasdaq Biotechnology invest in?
ProShares Trust - ProShares Ultra Nasdaq Biotechnology is an exchange traded fund launched and managed by ProShare Advisors LLC. It invests in public equity markets of the United States. It invests through derivatives in stocks of companies operating across health care, pharmaceuticals, biotechnology, drugs manufacturer, diagnostic development and life sciences sectors. It uses derivatives such as swaps to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track 2x the daily performance of the Nasdaq...